[1]
Pacheco, R.L. et al. 2020. Why COVID-19 trials should be blinded (as any other one). Journal of Evidence-Based Healthcare. 2, 1 (Apr. 2020), 25–27. DOI:https://doi.org/10.17267/2675-021Xevidence.v2i1.2841.